Literature DB >> 7950301

Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides.

C A Stein, A M Krieg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7950301     DOI： 10.1089/ard.1994.4.67

Source DB:  PubMed          Journal:  Antisense Res Dev        ISSN： 1050-5261


× No keyword cloud information.
  35 in total

Review 1.  Antisense pharmacodynamics: critical issues in the transport and delivery of antisense oligonucleotides.

Authors:  R L Juliano; S Alahari; H Yoo; R Kole; M Cho
Journal:  Pharm Res       Date:  1999-04       Impact factor: 4.200

2.  The experimental use of antisense oligonucleotides: a guide for the perplexed.

Authors:  C A Stein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Potent and selective gene inhibition using antisense oligodeoxynucleotides.

Authors:  W M Flanagan; R W Wagner
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 4.  Silencing disease genes in the laboratory and the clinic.

Authors:  Jonathan K Watts; David R Corey
Journal:  J Pathol       Date:  2011-11-09       Impact factor: 7.996

5.  Alternative for anti-TNF antibodies for arthritis treatment.

Authors:  Joseph Paquet; Christel Henrionnet; Astrid Pinzano; Jean-Baptiste Vincourt; Pierre Gillet; Patrick Netter; Isabelle Chary-Valckenaere; Damien Loeuille; Jacques Pourel; Laurent Grossin
Journal:  Mol Ther       Date:  2011-08-02       Impact factor: 11.454

6.  Proteolipid protein regulates the survival and differentiation of oligodendrocytes.

Authors:  X Yang; R P Skoff
Journal:  J Neurosci       Date:  1997-03-15       Impact factor: 6.167

Review 7.  In vitro and in vivo action of antisense RNA.

Authors:  W Nellen; G Sczakiel
Journal:  Mol Biotechnol       Date:  1996-08       Impact factor: 2.695

Review 8.  Antisense approaches to the gene therapy of cancer--'Recnac'.

Authors:  I Gibson
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

9.  Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides.

Authors:  P Rockwell; W J O'Connor; K King; N I Goldstein; L M Zhang; C A Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

10.  Native oligodeoxynucleotides specifically active against human immunodeficiency virus type 1 in vitro: a G-quartet-driven effect?

Authors:  L Tondelli; F P Colonna; A Garbesi; S Zanella; M E Marongiu; S Corrias; A G Loi; P La Colla
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.